F. Fanelli et al., Activation mechanism of human oxytocin receptor: A combined study of experimental and computer-simulated mutagenesis, MOLEC PHARM, 56(1), 1999, pp. 214-225
The aim of this study was to investigate the molecular changes associated w
ith the transition of the human oxytocin receptor from its inactive to its
active states. Mutation of the conserved arginine of the glutamate/aspartat
e-arginine-tyrosine motif located in the second intracellular domain gave r
ise to the first known constitutively active oxytocin receptor (R137A), whe
reas mutation of the aspartic acid located in the second transmembrane doma
in led to an inactive receptor (D85A). The structural features of the const
itutively active and inactive receptor mutants were compared with those of
the wild type in its free and agonist-bound states. The results suggest tha
t, although differently triggered, the activation process induced by the ag
onist and the activating mutation are characterized by the opening of a sol
vent exposed site formed by the 2nd intracellular loop, the cytosolic exten
sion of helix 5, and the 3rd intracellular loop; on the contrary, the D85A
mutation prevents oxytocin from triggering the opening of a cytosolic site.
On the basis of these findings, we hypothesize that this cytosolic crevice
plays an important role in G protein recognition. Finally, comparative ana
lysis of the free- and agonist-bound forms of the wild-type oxytocin recept
or and alpha(1B) adrenergic receptor suggests that the highly conserved pol
ar amino acids and the seven helices play similar mechanistic roles in the
different G protein-coupled receptors.